Genetical and physical interactions between Esc2 and the SUMO-pathway. (A) BD-ESC2 in combination with AD-SMT3, AD-yUBC9, or pGAD424 (empty vector) was transformed in the wild-type strain (HY0803), and the interactions examined by the β-gal assay. (B) Two-hybrid analysis of Sgs1 interaction with Ubc9 and SUMO. BD-SGS1 in combination with AD-UBC9, AD-SMT3, and pGAD424 was transformed in wild-type (FY0101) or esc2Δ (HY0705) strains, and the interaction was examined by the β-gal assay (C) Tetrad analysis of esc2 slx8 strains. (D) Spot assay of the MMS sensitivity of wild-type (SY2234), esc2Δ (FY1081), mms21-CH (FY1003), mms21-11 (FY1012), siz1Δ (HY0628), siz2Δ (HY0634), esc2Δ mms21-CH (RDY354), esc2Δ mms21-11 (RDY355), esc2Δ siz1Δ (RDY137), and esc2Δ siz2Δ (RDY358) strains.